Risk of Incident Psychosis and Mania With Prescription Amphetamines
Although use of hospitalized control subjects excludes individuals with less severe disease, leading to selection bias, the study results suggest that caution should be exercised when prescribing high doses of amphetamines, with regular screening for symptoms of psychosis or mania.
Authors
- Lauren V. Moran (ORCID: https://orcid.org/0000-0002-5185-1767)
- Döst Öngür (ORCID: https://orcid.org/0000-0001-8151-5759)
- Cemre Erkol
- Jaisal Merchant (ORCID: https://orcid.org/0000-0002-9644-9915)
- Vinod Rao (ORCID: https://orcid.org/0000-0002-2868-5000)
- Joseph P. Skinner (ORCID: https://orcid.org/0000-0001-9566-0287)
- Ann K. Shinn (ORCID: https://orcid.org/0000-0002-5311-6280)
- Talia R. Cohen (ORCID: https://orcid.org/0000-0002-9791-2414)
- Roy H. Perlis (ORCID: https://orcid.org/0000-0002-5862-6757)
- Christin A. Mujica (ORCID: https://orcid.org/0000-0001-5033-0639)
- Kathryn Nielsen
- S. Trevor Taylor
Institutions
- McLean Hospital (US)
Publication Details
- Journal
- American Journal of Psychiatry
- Published
- 2024-09-12
- DOI
- https://doi.org/10.1176/appi.ajp.20230329
- Citations
- 24
- Primary Topic
- Attention Deficit Hyperactivity Disorder
- Type
- article
- Field-Weighted Citation Impact
- 9.25
Funders
- National Institute of Mental Health